共 10 条
[1]
State of the art and future directions of pancreatic ductal adenocarcinoma therapy[J] . Cindy Neuzillet,Annemila? Tijeras-Raballand,Philippe Bourget,Jér?me Cros,Anne Couvelard,Alain Sauvanet,Marie-Pierre Vullierme,Christophe Tournigand,Pascal Hammel. Pharmacology and Therapeutics . 2015
[2]
Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity[J] . J.A. Jara,R. López-Mu?oz. Pharmacological Research . 2015
[4]
Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death[J] . Agnieszka Sliwinska,Aneta Rogalska,Agnieszka Marczak,Jacek Kasznicki,Jozef Drzewoski. Toxicology in Vitro . 2015 (5)
[7]
Glioma Stem Cells: Markers, Hallmarks and Therapeutic Targeting by Metformin[J] . Joseph Najbauer,Nikola Kraljik,Péter Németh. Pathology & Oncology Research . 2014 (4)
[8]
Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer[J] . Tae Hun Kim,Dong Hoon Suh,Mi-Kyung Kim,Yong Sang Song,Daisuke Aoki. BioMed Research International . 2014
[10]
Hallmarks of Cancer: The Next Generation[J] . Douglas Hanahan,Robert A. Weinberg. Cell . 2011 (5)